ONL Therapeutics, Inc.
Biotechnology company · Ann Arbor, Michigan, United States
ONL Therapeutics, Inc. is a biotechnology company headquartered in Ann Arbor, Michigan, United States. Its earliest recorded incorporation is in 2011. It has received 5 US government small-business research awards (SBIR/STTR) from health agencies, $4.4 million in total, most recently in 2020. It has reported private securities offerings to the US SEC, most recently $60 million sold in a notice filed in 2024.
ONL Therapeutics at a glance
What does ONL Therapeutics do?
US government research funding
5 SBIR/STTR small-business research awards from US health agencies, $4.4 million in total (2012 to 2020). NIH funding came from the National Eye Institute.
Private fundraising reported to the SEC
10 Form D notices; the most recent reported $60 million sold (2024).
Frequently asked questions about ONL Therapeutics
Where is ONL Therapeutics headquartered?
ONL Therapeutics, Inc. is headquartered in Ann Arbor, Michigan, United States.
What does ONL Therapeutics do?
ONL Therapeutics, Inc. is a biotechnology company.
When was ONL Therapeutics founded?
The earliest incorporation on record for ONL Therapeutics, Inc. is in 2011, according to public company registers.
Similar companies
- BlueWillow Biologics, Inc.Ann Arbor, Michigan, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.